Last reviewed · How we verify

NCT05678153: ACU222

Effect of Passive Smoking on Orofacial Dysfunction Among a Group of Egyptian Children: A Cohort Study

Status unknown Last updated 6 March 2023
What this trial tests

trial testing Nordic Orofacial Test-Screen (NOT-S) in Smoking in 20 participants. Status unknown.

Timeline
1 May 2023
Primary endpoint
1 June 2023
15 June 2023

Quick facts

Lead sponsorAhram Canadian University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment20
Start date1 May 2023
Primary completion1 June 2023
Estimated completion15 June 2023

Drugs / interventions tested

Conditions studied

Sponsor

Ahram Canadian University

Who can join

Adults 4 to 7, any sex, with Smoking or Orofacial Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the orofacial dysfunction in children who are subjected to passive smoking and to correlate its results to their saliva cotinine levels

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Smoking

Currently open trials in the same condition.

Other Ahram Canadian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05678153.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing